Reported Reactions

Devices › Device types

FDA product code OSM · class 2 · Ear, Nose, Throat

Hearing aid, air-conduction with wireless technology, prescription: medical device reports filed with FDA

700 reports carry this product code, 2013–2026; 3 brands with a page.

700
reports with this product code
0% of all MAUDE reports
111
reports, 12 months to August 2026
96 in the 12 months before
66.1%
classified as malfunction
62.3% across all reports
0%
classified as death, as reported
0.9% across all reports

Product code OSM is FDA's classification for "Hearing aid, air-conduction with wireless technology, prescription" (ear, Nose, Throat panel), a class 2 device. 700 medical device reports carry this product code, 0% of the MAUDE database, from February 2013 to August 2026.

111 reports arrived in the 12 months to August 2026, up 16% from 96 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (66.1%), injury (33.3%) and other (0.6%). 3 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Brands with this product code

BrandReportsLatest 12 monthsClassified as deathClassified as malfunction
GN Resound32090%78.4%
Signia421,1300.1%93.5%
Charger160%86.4%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Manufacturers named

Manufacturer (as written on reports)ReportsShare
Oticon Medical20.3%

Reports by month, five years

02141Sep 2021: 11Oct 2021: 2Nov 2021: 2Dec 2021: 02022Jan 2022: 0Feb 2022: 0Mar 2022: 2Apr 2022: 6May 2022: 8Jun 2022: 2Jul 2022: 5Aug 2022: 15Sep 2022: 14Oct 2022: 20Nov 2022: 13Dec 2022: 162023Jan 2023: 12Feb 2023: 13Mar 2023: 20Apr 2023: 16May 2023: 18Jun 2023: 16Jul 2023: 24Aug 2023: 16Sep 2023: 6Oct 2023: 6Nov 2023: 7Dec 2023: 42024Jan 2024: 18Feb 2024: 20Mar 2024: 41Apr 2024: 12May 2024: 18Jun 2024: 10Jul 2024: 9Aug 2024: 8Sep 2024: 15Oct 2024: 21Nov 2024: 11Dec 2024: 52025Jan 2025: 4Feb 2025: 4Mar 2025: 6Apr 2025: 7May 2025: 5Jun 2025: 7Jul 2025: 8Aug 2025: 3Sep 2025: 5Oct 2025: 5Nov 2025: 8Dec 2025: 112026Jan 2026: 2Feb 2026: 9Mar 2026: 6Apr 2026: 4May 2026: 13Jun 2026: 11Jul 2026: 10Aug 2026: 27

FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

Event type and report source

Event type

Death0%0
Injury33.3%233
Malfunction66.1%463
Other0.6%4
Not given0%0

Who filed

Manufacturer report87.9%615
Voluntary report10%70
User facility report0%0
Distributor report2%14
Not given0.1%1

Grey bar: all 26,136,888 MAUDE reports.

Device problems coded

Device problem (FDA code)ReportsShare
Overheating of device18326.1%
Detachment of device or device componentpart of the device came off15021.4%
Patient device interaction problem8612.3%
Product quality problem497%
Patient-device incompatibilitythe device did not suit the patient324.6%
Breakthe device broke304.3%
Insufficient device problem information182.6%
Battery problema problem with the battery162.3%
Fracturea broken bone162.3%
Material integrity problema problem with the device material142%
Material deformation121.7%
Temperature problem91.3%
Biocompatibility81.1%
Inadequacy of device shape and/or size60.9%
Lack of effect60.9%
Wireless communication problema wireless connection problem60.9%
Device-device incompatibility50.7%
Noise, audible50.7%
Output problem50.7%
Disconnection40.6%

Questions about hearing aid, air-conduction with wireless technology, prescription reports

What is product code OSM?

FDA's classification code for "Hearing aid, air-conduction with wireless technology, prescription", class 2, reviewed by the ear, Nose, Throat panel. Every device report carries the product code of the device involved.

How many reports carry this code?

700 reports through August 2026, 111 of them in the latest 12 months.

Which brands appear most often?

GN Resound (320), Signia (42) and Charger (1). Widely used products collect more reports because more people use them.

Can the brands table be used to rank the devices?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.